@article{2e6b6eb8969b4636af35e1dba45dd28b,
title = "Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis",
abstract = "Systemic sclerosis (SSc) is an autoimmune fibrotic disease whose pathogenesis is poorly understood and lacks effective therapies. We undertook quantitative analyses of T cell infiltrates in the skin of 35 untreated patients with early diffuse SSc and here show that CD4+ cytotoxic T cells and CD8+ T cells contribute prominently to these infiltrates. We also observed an accumulation of apoptotic cells in SSc tissues, suggesting that recurring cell death may contribute to tissue damage and remodeling in this fibrotic disease. HLA-DR-expressing endothelial cells were frequent targets of apoptosis in SSc, consistent with the prominent vasculopathy seen in patients with this disease. A circulating effector population of cytotoxic CD4+ T cells, which exhibited signatures of enhanced metabolic activity, was clonally expanded in patients with systemic sclerosis. These data suggest that cytotoxic T cells may induce the apoptotic death of endothelial and other cells in systemic sclerosis. Cell loss driven by immune cells may be followed by overly exuberant tissue repair processes that lead to fibrosis and tissue dysfunction.",
author = "Takashi Maehara and Naoki Kaneko and Perugino, {Cory A.} and Hamid Mattoo and Jesper Kers and Hugues Allard-Chamard and Mahajan, {Vinay S.} and Hang Liu and Murphy, {Samuel J.H.} and Musie Ghebremichael and David Fox and Payne, {Aimee S.} and Robert Lafyatis and Stone, {John H.} and Dinesh Khanna and Shiv Pillai",
note = "Funding Information: We thank Candace Gregg for assistance in organizing the manuscript. This work was supported by the NIH Autoimmune Cen- ters of Excellence funding to SP, DK, and DF including U19 AI 110495 to SP and UM1 AI110498 to DK and DF. CAP was supported by a Rheumatology Research Foundation Scientist Development Award and a Sponsored Research Agreement with Union Chimique Belge (UCB). TM was supported by JSPS JP18KK0260 and the Takeda Science Foundation. JK was supported by a Work Visit Grant of the Amsterdam Infection and Immunity Institute. VSM was supported by AI113163 from the NIH. MG was supported by NIAID P30AI060354. ASP was supported in part by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant P30-AR06958. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAMS or the NIH. Funding Information: We thank Candace Gregg for assistance in organizing the manuscript. This work was supported by the NIH Autoimmune Centers of Excellence funding to SP, DK, and DF including U19 AI 110495 to SP and UM1 AI110498 to DK and DF. CAP was supported by a Rheumatology Research Foundation Scientist Development Award and a Sponsored Research Agreement with Union Chimique Belge (UCB). TM was supported by JSPS JP18KK0260 and the Takeda Science Foundation. JK was supported by a Work Visit Grant of the Amsterdam Infection and Immunity Institute. VSM was supported by AI113163 from the NIH. MG was supported by NIAID P30AI060354. ASP was supported in part by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant P30-AR06958. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAMS or the NIH. Publisher Copyright: Copyright: {\textcopyright} 2020, American Society for Clinical Investigation.",
year = "2020",
month = may,
day = "1",
doi = "10.1172/JCI131700",
language = "English",
volume = "130",
pages = "2451--2464",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "5",
}